BR112013012175A2 - combination, co-administration, use and method - Google Patents

combination, co-administration, use and method

Info

Publication number: BR112013012175A2
Authority: BR; Brazil
Prior art keywords: administration; combination
Prior art date: 2010-11-17

Application number

BR112013012175A

Other languages

Portuguese (pt)

Inventor

C Ong Christy

Koeppen Hartmut

P Hoeflich Klaus

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-11-17

Filing date

2011-11-14

Publication date

2019-09-24

2011-11-14 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2019-09-24 Publication of BR112013012175A2 publication Critical patent/BR112013012175A2/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/105—Persulfides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

BR112013012175A 2010-11-17 2011-11-14 combination, co-administration, use and method BR112013012175A2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US41467110P	2010-11-17	2010-11-17
US201161523062P	2011-08-12	2011-08-12
PCT/EP2011/070008 WO2012065935A1 (en)	2010-11-17	2011-11-14	Methods of treating tumors

Publications (1)

Publication Number	Publication Date
BR112013012175A2 true BR112013012175A2 (en)	2019-09-24

Family

ID=44993549

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR112013012175A BR112013012175A2 (en)	2010-11-17	2011-11-14	combination, co-administration, use and method

Country Status (9)

Country	Link
EP (1)	EP2640369A1 (en)
JP (1)	JP2013542965A (en)
KR (1)	KR20130121122A (en)
CN (1)	CN103298461A (en)
BR (1)	BR112013012175A2 (en)
CA (1)	CA2817133A1 (en)
MX (1)	MX2013005507A (en)
RU (1)	RU2013126036A (en)
WO (1)	WO2012065935A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2775601C (en)	2009-09-28	2017-10-03	Qilu Pharmaceutical Co., Ltd	4-(substituted anilino)-quinazoline derivatives useful as tyrosine kinase inhibitors
CN104640865B (en)	2012-09-19	2018-05-11	诺华股份有限公司	Pyrrolin alkane subbase-pyrimidine as kinase inhibitor
SG11201507477XA (en) *	2013-03-14	2015-10-29	Genentech Inc	Combinations of a mek inhibitor compound with an her3/egfr inhibitor compound and methods of use
US11517539B2 (en)	2016-02-15	2022-12-06	University Of Georgia Research Foundation, Inc.	IPA-3-loaded liposomes and methods of use thereof
KR102351270B1 (en) *	2016-06-16	2022-01-14	하얼빈 젠바오 파마슈티컬 컴퍼니, 리미티드	Akt inhibitor dihydropyrazoloazepine compounds
US20220218715A1 (en) *	2019-05-22	2022-07-14	Voronoi Co., Ltd.	Novel use of pyrrolo-pyridine derivative compound for prevention and/or treatment of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2593428C (en)	2005-01-10	2012-04-17	Pfizer Inc.	Pyrrolopyrazoles, potent kinase inhibitors
EP1869052A1 (en)	2005-04-06	2007-12-26	AstraZeneca AB	Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
WO2007023382A2 (en)	2005-08-25	2007-03-01	Pfizer Inc.	Pyrimidine amino pyrazole compounds, potent kinase inhibitors
AP2369A (en)	2005-12-21	2012-02-29	Pfizer Prod Inc	Carbonylamino pyrrolopyrazoles, potent kinase inhibitors.
CA2691251A1 (en) *	2007-06-19	2008-12-24	Yoshikazu Ohta	Preventive/remedy for cancer
US7998688B2 (en) *	2008-03-07	2011-08-16	OSI Pharmaceuticals, LLC	Inhibition of EMT induction in tumor cells by anti-cancer agents
US8674095B2 (en)	2008-12-19	2014-03-18	Afraxis Holdings, Inc.	Compounds for treating neuropsychiatric conditions

2011
- 2011-11-14 RU RU2013126036/15A patent/RU2013126036A/en not_active Application Discontinuation
- 2011-11-14 MX MX2013005507A patent/MX2013005507A/en not_active Application Discontinuation
- 2011-11-14 JP JP2013539214A patent/JP2013542965A/en active Pending
- 2011-11-14 KR KR1020137015302A patent/KR20130121122A/en not_active Application Discontinuation
- 2011-11-14 BR BR112013012175A patent/BR112013012175A2/en not_active IP Right Cessation
- 2011-11-14 WO PCT/EP2011/070008 patent/WO2012065935A1/en active Application Filing
- 2011-11-14 CN CN2011800644319A patent/CN103298461A/en active Pending
- 2011-11-14 CA CA2817133A patent/CA2817133A1/en not_active Abandoned
- 2011-11-14 EP EP11784634.5A patent/EP2640369A1/en not_active Withdrawn

Also Published As

Publication number	Publication date
JP2013542965A (en)	2013-11-28
WO2012065935A1 (en)	2012-05-24
CA2817133A1 (en)	2012-05-24
CN103298461A (en)	2013-09-11
RU2013126036A (en)	2014-12-27
KR20130121122A (en)	2013-11-05
EP2640369A1 (en)	2013-09-25
MX2013005507A (en)	2013-07-17

Similar Documents

Publication	Publication Date	Title
BR112012031232A2 (en)	2016-10-25	method, device and use
SMT201600226B (en)	2016-08-31	SOME ADMINOPYRIMIDINS, THEIR COMPOSITIONS AND METHODS FOR THEIR USE
BR112012002349A2 (en)	2015-10-13	compound and use thereof
BR112013007506A2 (en)	2016-07-12	pyridinones / pyrazinones - creation and use methods
BR112013010725A2 (en)	2016-07-05	Method and composition
BR112012022879A2 (en)	2016-06-14	compound, pharmaceutical composition, compound use and treatment method
BRPI1012861A2 (en)	2018-02-27	catalyst and catalyst use
BR112014031262A2 (en)	2017-06-27	innovative biocatalyst compositions and processes for use.
BRPI1012533A2 (en)	2015-09-22	pyradazinone compound and use thereof
BR112012031226A2 (en)	2018-03-06	compound, compound use, pharmaceutical composition, and pharmaceutical composition use
BR112012003792A2 (en)	2016-04-19	topical gel and use of topical gel.
BR112013013584A2 (en)	2016-09-06	endoscope and method
BR112013010988A2 (en)	2016-07-26	fluid composition and use
BR112013006016A2 (en)	2016-06-07	azabenzothiazole compounds, compositions and methods of use
BR112013013523A2 (en)	2016-10-11	centralizer, method, and, use of a centralizer
BRPI1007494A2 (en)	2016-02-16	compound and use thereof
SMT201700064B (en)	2017-03-08	D2 ANTAGONISTS, METHODS OF SYNTHESIS AND METHODS OF USE
IT1403847B1 (en)	2013-11-08	PHARMACEUTICAL COMPOSITIONS INCLUDING RIFAXIMINA AND THEIR USE.
BRPI1006996A2 (en)	2015-09-15	composition, method and use
BR112014009178A2 (en)	2018-09-04	methods, use, receptor and invention
BRPI0919794A2 (en)	2015-12-15	device for intracorporeal use, and composed
BR112014009476A2 (en)	2017-06-13	reflector, illuminator and illuminator use
CO6781486A2 (en)	2013-10-31	Compounds and their use
BRPI1011036A2 (en)	2017-09-26	use
BR112014026873A2 (en)	2017-06-27	cosmetic method, cosmetic composition and use.

Legal Events

Date	Code	Title	Description
2019-10-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2020-01-21	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.